Infographic: Top Three Reasons Why the Expanded IPM-Janssen Partnership is a Boost to Women's Health

In May 2014, IPM and Janssen R&D Ireland, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, expanded their longstanding collaboration for the development and delivery of sexual and reproductive health products containing the antiretroviral drug dapivirine. See the top reasons why this agreement is important for women.